Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders

Author： Adan R.A.H.   Vink T.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.11, Iss.6, 2001-12, pp. : 483-490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoproteomics Applications for Drug Target Discovery in CNS Disorders

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 2, 2011-06 ,pp. : 102-122

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin receptors: new opportunities in drug discovery

By Wikberg J.E.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 1, 2001-01 ,pp. : 61-76

Informa Healthcare

Access to resources Recommend Favorite

Melanocortin Receptors as Drug Targets for Disorders of Energy Balance

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 251-261

Bentham Science Publishers

Access to resources Recommend Favorite

The Melanocortin System as a Therapeutic Treatment Target for Adiposity and Adiposopathy

By Bays Harold  

Drugs in R&D, Vol. 7, Iss. 5, 2006-01 ,pp. : 289-302

Adis International

Access to resources Recommend Favorite

Drug Discovery and Target Validation

By  

Cells Tissues Organs, Vol. 169, Iss. 3, 2001-06 ,pp. : 265-271

Karger

Access to resources Recommend Favorite